US FDA approved iCAD Inc.'s PMA for its PowerLook Tomo Detection solution for breast tumor detection March 24. The firm says the product is the first ever concurrent-read computer aided detection (CAD) solution for digital breast tomosynthesis (DBT).
Current CAD systems are generally designed to analyze images from 2D mammography systems, which typically produce a total for four images per exam, after a scan. That approach has caused some frustration for radiologists who have adopted 3D tomosynthesis, which can product hundreds of images, because of the significantly longer read time
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?